RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bio Rad Laboratories Stock

Bio Rad Laboratories Equity 2025

Bio Rad Laboratories Equity

6.57 B USD

Ticker

BIO

ISIN

US0905722072

WKN

865406

In 2025, Bio Rad Laboratories's equity was 6.57 B USD, a -24.85% increase from the 8.74 B USD equity in the previous year.

Bio Rad Laboratories Aktienanalyse

What does Bio Rad Laboratories do?

Bio-Rad Laboratories Inc. is a leading company in the field of scientific research based in Hercules, California. The company was founded in 1952 by two brothers and has since developed into a multinational company with over 8,000 employees worldwide. Bio-Rad has branches in over 100 countries and its products are used in biotechnology, pharmaceuticals, and the food industry. History Bio-Rad was founded in 1952 by the couple David and Alice Schwartz. They started with the production of blood group serology tests and later expanded their product range to include immunchemicals, electrophoresis equipment, and antibodies. In the 1970s, Bio-Rad developed the first commercial protein A purification system, which is still an important component of protein research today. Business model Bio-Rad's business model is focused on providing high-quality products and services to support customers in their scientific research. The company has various divisions such as life science research, clinical diagnostics, and life science education, which offer products and solutions for scientists, researchers, and diagnosticians. Life science research The life science research division offers a wide range of products and services for biological research. This includes PCR systems, electrophoresis equipment, antibodies, proteins, cell counters, and much more. Bio-Rad's products are used by scientists and researchers around the world to better understand the intricacies of life and the mechanisms of diseases. Clinical diagnostics Bio-Rad's clinical diagnostics division provides a broad spectrum of diagnostic products and solutions for hospitals, laboratories, and medical facilities. The company provides clinical diagnostic instruments, reagents, testing systems, and software to support the diagnostic process. Life science education The life science education division offers innovative and interactive teaching and learning materials for scientific research to teachers, professors, and students. Bio-Rad's products and solutions support the better understanding of the intricacies of life and the mechanisms of diseases in the fields of biology, chemistry, and physics. Products Bio-Rad offers a wide range of products and solutions for research and diagnostics. These include, among others: PCR systems: Bio-Rad offers various PCR systems that help researchers and diagnosticians amplify and analyze DNA. The systems are highly precise and provide reliable results. Proteins and antibodies: Bio-Rad offers a wide selection of proteins and antibodies for research and diagnostics. The products include various types of proteins and antibodies needed for the analysis of protein functions and interactions. Electrophoresis equipment: Bio-Rad provides various electrophoresis equipment that plays an important role in research and diagnostics. The products include gel electrophoresis systems, Western blot systems, and devices for protein analysis. Clinical diagnostics: Bio-Rad offers a wide range of diagnostic products for hospitals, laboratories, and medical facilities. These include immunoassay products, blood group serology tests, and devices for the diagnosis of infectious diseases. In summary, Bio-Rad Laboratories Inc. is a leading company in the field of scientific research. The company offers a wide range of products and solutions for research and diagnostics, supporting scientists, researchers, and diagnosticians around the world in exploring the intricacies of life and better understanding diseases. Bio Rad Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Bio Rad Laboratories's Equity

Bio Rad Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bio Rad Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bio Rad Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bio Rad Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bio Rad Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bio Rad Laboratories stock

What is the equity of Bio Rad Laboratories this year?

Bio Rad Laboratories has equity of 6.57 B USD this year.

What was the equity of Bio Rad Laboratories compared to the previous year?

The equity of Bio Rad Laboratories has increased/decreased by -24.85% decreased compared to the previous year.

What impact does a high equity have on investors of Bio Rad Laboratories?

A high equity is advantageous for investors of Bio Rad Laboratories as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Bio Rad Laboratories?

A low equity can be a risk for investors of Bio Rad Laboratories, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Bio Rad Laboratories affect the company?

An increase in equity of Bio Rad Laboratories can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Bio Rad Laboratories affect the company?

A reduction in equity of Bio Rad Laboratories can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Bio Rad Laboratories?

Some factors that can affect the equity of Bio Rad Laboratories include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Bio Rad Laboratories so important for investors?

The equity of Bio Rad Laboratories is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Bio Rad Laboratories take to change the equity?

To change equity, Bio Rad Laboratories can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Bio Rad Laboratories pay?

Over the past 12 months, Bio Rad Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bio Rad Laboratories is expected to pay a dividend of 0 USD.

What is the dividend yield of Bio Rad Laboratories?

The current dividend yield of Bio Rad Laboratories is .

When does Bio Rad Laboratories pay dividends?

Bio Rad Laboratories pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bio Rad Laboratories?

Bio Rad Laboratories paid dividends every year for the past 0 years.

What is the dividend of Bio Rad Laboratories?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bio Rad Laboratories located?

Bio Rad Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bio Rad Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bio Rad Laboratories from 6/25/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/25/2025.

When did Bio Rad Laboratories pay the last dividend?

The last dividend was paid out on 6/25/2025.

What was the dividend of Bio Rad Laboratories in the year 2024?

In the year 2024, Bio Rad Laboratories distributed 0 USD as dividends.

In which currency does Bio Rad Laboratories pay out the dividend?

The dividends of Bio Rad Laboratories are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bio Rad Laboratories stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Bio Rad Laboratories

Our stock analysis for Bio Rad Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio Rad Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.